African Americans and European Americans exhibit distinct gene expression patterns across tissues and tumors that are associated with immunologic and infectious functions and environmental exposures by Singh, Urminder et al.
Genetics, Development and Cell Biology 
Publications Genetics, Development and Cell Biology 
10-8-2020 
African Americans and European Americans exhibit distinct gene 
expression patterns across tissues and tumors that are 
associated with immunologic and infectious functions and 
environmental exposures 
Urminder Singh 
Iowa State University, usingh@iastate.edu 
Kyle M. Hernandez 
University of Chicago 
Bruce J. Aronow 
Cincinnati Children’s Hospital Medical Center 
Eve Syrkin Wurtele 
Iowa State University, mash@iastate.edu 
Follow this and additional works at: https://lib.dr.iastate.edu/gdcb_las_pubs 
 Part of the Cell and Developmental Biology Commons, Genetics and Genomics Commons, and the 
Immunology and Infectious Disease Commons 
The complete bibliographic information for this item can be found at https://lib.dr.iastate.edu/
gdcb_las_pubs/262. For information on how to cite this item, please visit 
http://lib.dr.iastate.edu/howtocite.html. 
This Article is brought to you for free and open access by the Genetics, Development and Cell Biology at Iowa State 
University Digital Repository. It has been accepted for inclusion in Genetics, Development and Cell Biology 
Publications by an authorized administrator of Iowa State University Digital Repository. For more information, 
please contact digirep@iastate.edu. 
African Americans and European Americans exhibit distinct gene expression 
patterns across tissues and tumors that are associated with immunologic and 
infectious functions and environmental exposures 
Abstract 
The COVID-19 pandemic has affected African American populations disproportionately with respect to 
prevalence, morbidity, and mortality. Because gene expression profiles represent combined genetic, 
socioenvironmental, and physiological effects, and could provide therapeutic biomarkers and 
environmental mitigation strategies, we undertook a large-scale assessment of differential gene 
expression between African Americans and European Americans. To do this, we mined RNA-Seq datasets 
from normal and diseased (tumor) conditions whose metadata could be used to evaluate differential 
patterns. We observed widespread differential expression of genes implicated in COVID-19 and integral to 
epithelial boundary function, inflammation, infection, and reactive oxygen stress. Notably, expression of 
the little-studied F8A2 gene is up to 40-fold greater in African Americans. F8A2, like F8A1, encodes 
HAP40 protein, which mediates early endosome movement. African American gene expression 
signatures reveal increased number or activity of esophageal glandular cells and lung ACE2-positive basal 
keratinocytes. These findings have potential to establish prognostic signatures, refine approaches to 
minimizing risk of severe infection, and improve precision treatment of COVID-19. 
Disciplines 
Cell and Developmental Biology | Genetics and Genomics | Immunology and Infectious Disease 
Comments 
This preprint is made available through Research Square, doi: 10.21203/rs.3.rs-88890/v1. 
Creative Commons License 
This work is licensed under a Creative Commons Attribution 4.0 License. 
This article is available at Iowa State University Digital Repository: https://lib.dr.iastate.edu/gdcb_las_pubs/262 
African Americans and European Americans exhibit
distinct gene expression patterns across tissues
and tumors that are associated with immunologic
and infectious functions and environmental
exposures
Urminder Singh1,2,3, Kyle M. Hernandez4,5, Bruce J. Aronow6, and Eve Syrkin Wurtele1,2,3*
1Bioinformatics and Computational Biology Program, Iowa State University, Ames, IA, 50011, USA
2Center for Metabolic Biology, Iowa State University, Ames, IA, 50011, USA
3Genetics Development and Cell Biology, Iowa State University, Ames, IA, 50011, USA
4Department of Medicine, University of Chicago, Chicago, IL, 60637
5Center for Translational Data Science, University of Chicago, Chicago, IL, 60637
6Biomedical Informatics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229
*mash@iastate.edu
ABSTRACT
The COVID-19 pandemic has affected African American populations disproportionately with respect to prevalence, morbidity,
and mortality. Because gene expression profiles represent combined genetic, socioenvironmental, and physiological effects,
and could provide therapeutic biomarkers and environmental mitigation strategies, we undertook a large-scale assessment of
differential gene expression between African Americans and European Americans. To do this, we mined RNA-Seq datasets
from normal and diseased (tumor) conditions whose metadata could be used to evaluate differential patterns. We observed
widespread differential expression of genes implicated in COVID-19 and integral to epithelial boundary function, inflammation,
infection, and reactive oxygen stress. Notably, expression of the little-studied F8A2 gene is up to 40-fold greater in African
Americans. F8A2, like F8A1, encodes HAP40 protein, which mediates early endosome movement. African American
gene expression signatures reveal increased number or activity of esophageal glandular cells and lung ACE2-positive basal
keratinocytes. These findings have potential to establish prognostic signatures, refine approaches to minimizing risk of severe
infection, and improve precision treatment of COVID-19.
Introduction
The COVID-19 pandemic has infected over 31 million people and killed over 970,000 worldwide as of September, 2020
(https://coronavirus.jhu.edu/map.html). Its causative agent, the novel SARS-CoV-2, is an enveloped single stranded RNA
virus that infects tissues including epithelial cells in the upper respiratory tract, lung alveoli, GI tract, vasculature endothelium,
renal tubules, central nervous system, and myocardium1–6. The complex combinations and severities of symptoms caused
by SARS-CoV-2 include fever, cough, fatigue, dyspnea, diarrhea, thrombosis, stroke, acute respiratory failure, renal failure,
cardiac failure; in some individuals these may lead to long-term disability or death2, 5, 6. Differing patterns of disease may result
from direct cellular infection, secondary inflammatory repercussions, and circulating immune and necrotic complexes from
distal sites of infection and response7–9. How these attributes confer risk of increased disease severity to individuals is not well
understood4, 8, 10, 11. Identifying individuals most at-risk for severe COVID-19 infection, and determining the molecular and
physiological basis for this risk, is critical to enable more informed public health decisions, and improving our identification
and use of precision interventions.
COVID-19 cases and deaths are disproportionately higher among African Americans in the US10. This disparity is caused
in part by complex combinations of socio-economic factors, including underlying comorbidities, air quality, population density,
and health care access10. Heritable factors in the human host also influence COVID-19 symptoms12–16. To date, several genetic
determinants of COVID-19 severity have been partially elucidated. Genetic variants of Angiotensin-Converting Enzyme2
(ACE2), a major human host receptor for the SARS-CoV-2 spike protein, may be linked to increased infection by COVID-1915.
Human Leukocyte Antigen (HLA) gene alleles have been associated with susceptibility to diabetes and SARS-CoV-214. A
COVID-19 association at locus 9q34.2 spans several genes related to COVID-19, including blood type13. The genetic propensity
in southern European populations for mutations in the pyrin-encoding Mediterranean Fever gene (MEFV) has been proposed to
lead to elevated levels of pro-inflammatory molecules, a cytokine storm, and greater severity of COVID-1916. Multiple GWAS
associations based on ancestry are beginning to emerge (https://grasp.nhlbi.nih.gov/Covid19GWASResults.aspx)13.
Gene expression is a reflection of a cell’s composition and its spatial and developmental context in an organism. Modifying
factors that determine gene expression span genetics, and physiological, environmental, and socioeconomic influences. In this
study we seek to investigate potential differential expression of genes and pathways that may impact the severity of COVID-19
infection in African Americans. Research with macrophage cell lines has identified ancestry-related differences in innate
immune response to bacterial pathogens, with cell lines isolated from individuals with African ancestry more likely to exhibit
stronger inflammatory responses17.
Here, we utilize publicly available datasets to explore gene expression differences between African American and European
American individuals. We analyze "non-diseased" tissues from the Genotype Tissue Expression (GTEx, https://gtexportal.org/home/)
project, and, as representative of highly perturbed systems, tumor samples from The Cancer Genome Atlas (TCGA,https://www.cancer.gov/about-
nci/organization/ccg/research/structural-genomics/tcga). In addition, we seek to unravel the cellular origins of ancestry-
associated differential gene expression through the use of Human Cell Atlas single-cell datasets from esophagus and lung
tissues. Taken together, our analyses reveal that European Americans and African Americans have significant differences in
expression of multiple genes across most sample-types. Pathways likely to impact the severity of COVID-19 are enriched
in these DE genes. In esophagus and lung, two tissues critical to early SARS-CoV-2 infections, population-differential gene
signatures implicate specific cell lineages that are likely to alter viral disease severity. Finally, we highlight the importance of
evaluating population-related impacts on gene expression in the context of cellular and organismal health and resilience to
disease in the combined light of socioeconomic/environmental and genetic factors.
Results
In order to identify genes differentially-expressed (DE) between African American and European Americans we constructed an
aggregated dataset of 7,142 RNA-Seq samples encompassing nine non-diseased tissues from GTEx and eight cancers from
TCGA18, 19. Race assignments are self-reported in the metadata; however, many of the individuals sampled identifying as a
single race may be from an admixed population20, 21. We analyzed data and metadata using MetaOmGraph (MOG)18, software
that supports interactive exploratory analysis of large data to identify and distinguish patterns across multiple dimensions (Table
1 and Supplementary Table S1).
Genes are DE between populations in a tissue- and tumor-specific manner
DE genes were identified for each sample-type, as well as for pooled TCGA and GTEx data (Table 1 and Supplementary Tables
S2-S28). The number of samples affects the power of the DE test (Table 1). To test for potential confounding factors that might
explain gene expression pattern differences, we scrutinized differences between African American and European Americans
populations controlling for biologically-relevant factors (sex, age, tissue, and cancer sub-type); under these analysis, all DE
genes retained statistical significance (Supplementary Tables S29-S55). We used Hartigans’ dip test to each gene to evaluate bi-
or multi-modality in gene expression distributions which may imply presence of potential hidden variables that might affect
expression of that gene (Additional File 1).
Differences in gene expression between populations are enriched for the inflammation/cytokines, endoso-
mal development, and ROS metabolism network
GO terms related to the interrelated biological processes of inflammation/cytokines, endosomal development, and ROS
metabolism are overrepresented among those genes that are DE between African Americans and European Americans
(Supplementary Table S56). Similarly, Gene Set Enrichment Analysis (GSEA) of all of the 25 GTEx and TCGA sample-types
shows KEGG pathways of immune- and inflammation-related processes are highly enriched (Supplementary Table S57-S58);
the single most commonly-enriched pathway (found in 19 of the 25 sample-types) is "cytokine-cytokin receptor interaction"
Figure 1 and Additional File 2. The processes of oxidative metabolism/xenobiotic catabolism are enriched in 9 sample-types
(Figure 1 and Additional File 2). Pooled GTEx data detects coordinated changes between African Americans and European
Americans associated with four cytokine-related pathways and oxidative drug metabolism (Figure 1 and Supplementary Table
S57).
The seven genes most highly and consistently DE between African Americans vs European Americans across all sample-
types. are: C-C Motif Chemokine Ligand CCL3L3, mitochondrial Glutathione-S-Transferase GSTM1; Nuclear Pore Complex
Interacting Protein Family Member NPIPB15, Coagulation Factor VIII Associated genes F8A3 and F8A2; FAM21B; and serine
protease PRSS21. Of these, four are directly related to inflammation, endosomal development, and ROS metabolism. Each of
these genes is also DE in multiple tissues and cancers.
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Figure 1. Gene Set Enrichment Analysis (GSEA) enrichment of KEGG pathways in African Americans compared to
European Americans in pooled GTEx data. GSEA comprehensively analyses data for expression of all genes, rather than only
the DE genes. A. The most common pathways enriched among upregulated genes in African Americans for tissue-types in
GTEx. Complete list of enriched pathways and sample-types is in Additional File 2. CK-CK, cytokine-cytokine receptor
interaction; glutathione-oxidative metabolism includes (oxidative) metabolism of xenobiotics. The full enrichment analysis for
each sample-type is shown in Supplementary Table S57-S59. B. The five most highly enriched pathways among upregulated
genes of pooled samples from all sample-types in GTEx are: Tol-like receptor signaling; chemokine signaling; primary
immunodeficiency; viral protein interaction with cytokine and cytokine receptor; metabolism of xenobiotics by cytochrome
P450.
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Project sample-type #AA #EA #Upregulated #Downregulated
GTEx Breast 12 75 0 0
GTEx Prostate 13 89 0 0
GTEx Uterus 13 68 0 0
GTEx Liver 15 97 0 0
GTEx Stomach 29 159 4 6
GTEx Colon 41 292 13 9
GTEx Esophagus 80 564 19 11
GTEx Thyroid 43 267 25 30
GTEx Lung 39 269 45 20
TCGA Lung squamous cell carcinoma (LUSC) 28 337 2 0
TCGA Thyroid carcinoma (THCA) 25 292 3 3
TCGA Lung adenocarcinoma (LUAD) 48 368 16 5
TCGA Kidney renal papillary cell carcinoma (KIRP) 49 166 19 13
TCGA Uterine Corpus Endometrial Carcinoma (UCEC) 54 70 28 5
TCGA Colon adenocarcinoma (COAD) 54 188 30 21
TCGA Kidney renal clear cell carcinoma (KIRC) 46 410 68 94
TCGA Breast invasive carcinoma (BRCA) 142 674 83 164
GTEx pooled GTEx samples 292 1,905 12 11
TCGA pooled TCGA samples 497 3,238 13 21
Table 1. Number of DE genes in African Americans (AA) compared to European Americans (EA) in nine
non-diseased tissue types and eight tumor types. Only sample-types with AA sample size 12 or greater are shown. Criteria
for DE: ą12 AA individuals sampled, ą2-fold difference in expression based on Mann-–Whitney U test (BH-corrected p-value
ă 0.05).
Cytokines, ROS and the storm
Multiple genes of the immune response are DE between African American and European American populations (Supplementary
Table S2-S25). The small inducible chemokine, CCL3L3, is more highly expressed in African Americans by up to 7-fold in
most diseased and non-diseased sample-types (Figure 2) (Supplementary Table S2-S25).
Several genes that mitigate oxidative stress are DE between African American and European American populations. In
particular, GSTM1, a key enzyme involved in oxidative stress, is more highly expressed in African Americans than European
Americans across multiple sample-types (Figure 2)).
F8As, endosome motility, and autophagy
Endocytosis and autophagy are intimately interrelated with COVID-1922. One little-studied player implicated in early endosome
motility23 is the F8A/HAP40 (HAP40) protein, encoded by three genes (F8A1, F8A2, and F8A3) in humans24.
F8A1 is more highly expressed by about 2-fold in European Americans under almost every sample-type analyzed (Figure
3). Conversely, F8A2 and F8A3 are more highly expressed in African Americans. Expression of F8A2 in African Americans
is up to 40-fold greater; expression of F8A3 is up to 6.6-fold greater. In LUSC, F8A2 and F8A3 are the only genes DE
ą 2-fold (Supplementary Table S7). F8A2 and F8A3 follow a similar trend, being more highly expressed in African Americans
(Supplementary Table S2-S25 and Figure 3 and Supplementary Figure 1
Because of the vast differences in expression levels of the three HAP40-encoding genes between African Americans and
European Americans, the paucity of literature on HAP4025, and the relationships among F8A1, F8A2, and F8A3 genes, we
further investigated the sequences, sequence variants, and the expression patterns of these genes.
The sequences of the HAP40-encoding proteins from F8A1, F8A2, and F8A3 are identical to each other in human reference
genome GRCh38.p13 (https://www.ncbi.nlm.nih.gov/assembly/GCF_000001405.39). We searched for
potential allele variants of HAP40 proteins encoded by F8A1, F8A2, and F8A3 in The Genome Aggregation Database
(gnomAD)26. gnomAD assigns individuals to populations, by clustering of genetic features. Our search identified only very
rare sequence variants in the HAP40s encoded by F8A1, F8A2, or F8A3 (gnomAD v3). No structural variants were identified
for HAP40 of F8A1 or F8A3; a duplication of 54 aa is, very rarely, present in F8A2 (gnomAD SVs v2.1).
To our knowledge, F8A1, F8A2 and F8A3 gene expression has never been compared. This may be because expression of
F8A2 and F8A3 genes is relatively low in most European Americans, and European Americans are the predominant population
studied. Furthermore, most RNA-Seq studies report expression of only F8A1 or F8A3 (and not F8A2), presumably aligning all
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Figure 2. Upregulated expression of CCL3L3 chemokine and mitochondrial glutathione-S-transferase GSTM1 in African
Americans compared to European Americans across multiple conditions. A. CCL3L3 is more highly expressed in African
Americans over a wide range of sample-types. CL3L3 binds to chemokine receptor proteins including CCR1, CCR3, and
CCR5. B. GSTM1 is more highly expressed in African Americans over a wide range of sample-types. GSTM1 is a key player
in metabolism of ROS and xenobiotics. (See Supplementary Tables S2-S28 for complete DE analysis). Violin plots summarize
expression over each sample across the two populations. AA, African American; EA, European American. Horizontal lines
represent mean log expression. ˚, MW test for DE significant (BH corrected p-value ă 0.05). ˚, Hartigans’ dip test, which
assesses bimodal distribution potentially corresponding to hidden covariates. For a given gene and sample-type, a bimodal
structure could imply presence of underlying hidden variables that affect expression of that gene, such as unreported
sub-population structure or other environmental/genetic factors affecting gene expression in that multi-cellular organism.
Expression distribution is also influenced by differences in population sizes (significant p-value ă 0.05). FC, fold change
AA/EA. GTEx and TCGA violin plots represent the pooled samples from each project. DE were computed within
MetaOmGraph (MOG)18, in MOG’s statistical analysis module; R scripts were executed interactively via MOG to generate the
violin plots.
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Figure 3. Differential expression of the HAP40 genes F8A1 and F8A2 in African Americans and European Americans across
multiple sample-types. HAP40 is a key molecular component of Huntington’s Disease, and shifts endosomal trafficking from
the microtubules to actin fibers23. A. F8A1 expression is upregulated in European Americans. B. F8A2 expression is
upregulated in African Americans. Violin plots summarize expression over each sample across the two populations. AA,
African American; EA, European American. Horizontal lines represent mean log expression. ˚, MW test for DE significant
(BH corrected p-value ă 0.05). ˚, Hartigans’ dip test, which assesses bimodal distribution potentially corresponding to hidden
covariates. For a given gene and sample-type, a bimodal structure could imply presence of underlying hidden variables that
affect expression of that gene, such as unreported sub-population structure or other environmental/genetic factors affecting
gene expression in that multi-cellular organism. Expression distribution is also influenced by differences in population sizes
(significant p-value ă 0.05). FC, fold change AA/EA. GTEx and TCGA violin plots represent the pooled samples from each
project. DE were computed within MetaOmGraph (MOG)18, in MOG’s statistical analysis module; R scripts were executed
interactively via MOG to generate the violin plots. (See Supplementary Figure 2 for line plot comparison across individuals)
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reads to one or the other gene.
We analyzed coexpression of the three F8A genes relative to the other 18,212 genes represented in the full TCGA-GTEx
dataset using two statistical measures: Pearson’s correlation and Mutual Information (MI). Although the three F8A genes are
proximately located on the X chromosome, their expression patterns are not correlated. F8A2 and F8A3 have a Pearson’s
correlation of (r “ 0.40), while F8A1 is negatively correlated with F8A2 and F8A3. Of all 18,212 genes represented in the
data, the expression pattern of F8A1 is most negatively (anti-) correlated with that of F8A2 (r “´0.45) and F8A3, (r “´0.24)
(Supplementary Table S60). F8A1 expression is not correlated with the F8 (Coagulation Factor FVIII) gene, although it resides
with intron 22 of this gene. MI analysis indicates that F8A2 and F8A3 genes are more closely associated with F8A1 than with
any other gene, consistent with the negative Pearson correlation (Supplementary Table S60).
Signatures of DE genes correspond to specific cell types in esophagus and lung
Because GTEx samples represent whole tissues, we sought to determine whether genes differentially expressed between African
Americans and European Americans corresponded to distinct cell populations present in these tissues. This would provide
information on cell-type representation across the two populations. To do this, we evaluated single cell datasets from two
tissues highly relevant for SARS-CoV-2 infection: esophagus and lung27, 28.
Genes upregulated in African Americans in the esophagus map predominantly to two cell lineages, glandular epithelial cells
of esophagus glands, and hematolymphoid lineage-associated dendritic cells (Figure 4). In proximal and distal airway cells of
the lung, the signature of DE genes in African Americans versus European Americans corresponds to basal differentiating and
proliferating keratinocytes (Figure 5).
Discussion
Human genetics contribute to the propensity and severity of diseases21, 30–37. Sometimes the contribution is straightforward;
a single allele variation found in Ashkenazi Jews, causes the vast majority of Tay-Sachs disease36. Sometimes it is more
complex; for example, hypertension is more prevalent in African American than European American populations37 in part due
to detrimental APOL1 mutations that are more frequent in West African populations31. Despite the paucity of studies focused
on Western African populations, the propensity and severity of other diseases among this population have been attributed to
genetics21, 31, 38, 39.
Many COVID-19 deaths have been attributed to a cyclic over-excitement of the innate immune system1, 7, 16. This process,
often termed a cytokine storm, results in a massive production of cytokines, and the body attacking itself rather than specifically
destroying the pathogen-containing cells1, 7. People with comorbidities, the elderly, and immunosuppressed individuals, may
be at a greater risk for COVID-19 morbidity and mortality either because they may not respond to infection with a sufficient
immune response40 and/or because they may be more likely to develop a cytokine storm1, 7. Notably, many cytokines and
other immunomodulatory molecules are DE between African Americans and European Americans in one or more sample-type,
cytokine-related KEGG pathways are enriched for DE genes, and cell-type biomarkers indicate enrichment of DE genes in
immune-related cell-types. Thus, predominant differences in gene expression, pathway enrichment, and cell-types between
African Americans and European Americans are all implicated in biological processes that highly impact COVID morbidity
and mortality.
CCL3L3, upregulated in African Americans under almost every diseased and non-diseased sample-type we tested, is also
upregulated in COVID-19-diseased human bronchoalveolar lavage fluid41. The CCL3 protein, encoded by CCL3L3, is a
member of the functionally-diverse C-C motif chemokine family and acts as ligand for CCR1, CCR3, and CCR5. CCL3 is a
neutrophil chemotaxis protein, recruiting and activating granulocytes, and inhibiting HIV-1-infection42. CCL3L3 is upregulated
in COVID-19, and neutrophils themselves are highly implicated in COVID-19 severity41, 43.
GSTM1, more highly expressed in African Americans compared to European Americans in almost every sample-type
evaluated, is a key enzyme in mitochondrial ROS metabolism44. Mitochondrially-generated ROS induce expression of
proinflammatory cytokines and chemokines, and are considered to play a key role in modulating innate immune responses
against RNA viruses44 including SARS-COV-245. Higher expression of GSTM1, could lead to increased mitochondrial ROS,
which might ultimately trigger inflammation and a cytokine storm44. Alternatively, higher GSTM1 expression might cause
ROS to be metabolized rapidly, and prevented ROS from initiating a sufficient immune response. GSTM1 has a second critical
function– in metabolism of xenobiotics, including many toxins and pharmaceuticals44. Thus, if GSTM1 is highly expressed,
pharmaceuticals may be rapidly metabolized and rendered inactive.
The most dramatic differences in genes expression in African Americans compared to European Americans are associated
with the highly-conserved but little-studied F8A genes, which each encode HAP40. F8A1 is upregulated in European Americans,
while F8A2 and F8A3 are upregulated in African Americans. HAP40 function has been researched mostly in the context of
F8A1 and the critical role of that gene in slowing early endosome mobility in Huntington’s disease24. In Huntington’s, HAP40
forms a bridge between the huntingtin protein and the regulatory small guanosine triphosphatase, RAB5; formation of this
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Figure 4. Esophageal gene signatures vary in African Americans and European Americans in a cell-specific manner. Gene
signature upregulated in African American versus European American esophagus maps to two cell lineages with prominent
presence in the human cell atlas (https://data.humancellatlas.org/) esophageal dataset. One significant fraction of the African
American-upregulated gene signature maps to glandular mucous epithelial cells of esophogeal glands (genes marked by red, far
right bar). Expression of several of the genes upregulated in African Americans is highly restricted to the mucous epithelial
cells (TSAPN8, PRR4, ELAPOR1), whereas FOLR1, for example, is more highly expressed in the ductal epithelial cells of the
gland. A second, smaller, signature corresponds to hematolymphoid/myeloid lineage dendritic cells, as shown by CDC1C,
PLD4, HERPUD1, and LPXN (genes marked by green, far right bar). In addition to a number of genes that are most strongly
expressed by those cell types, there are several genes that are essentially exclusively expressed by those cells.
ToppCell-constructed gene modules (http://toppcell.cchmc.org) for each of the cell types reported to be present in the large
scRNA-Seq dataset from esophagus29.
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Figure 5. Lung gene signatures upregulated in African Americans versus European Americans map to proximal airway
keratinocytic epithelial lineage, and to mesenchymal mesothelial and neuroendocrine cells. Marker genes for kerotinocytes
(genes marked by yellow, far right bar); ciliated epithelial cells (genes marked by turquoise, far right bar); mesothelial
mesenchymal cells (genes marked by red, far right bar); and neuroendocrine mesenchymal cells (mesenchymal). Note that the
keratinocytic proximal basal epithelial cell is the cell subtype with the highest expression of ACE2 receptor, a major target of
COVID-19 (ACE2 marked by black on bar at right). ToppCell-constructed gene modules (http://toppcell.cchmc.org) for each of
the cell types reported to be present in the large scRNA-Seq dataset from lung28.
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complex reduces endosomal motility by shifting endosomal trafficking from the microtubule to the actin cytoskeleton23. F8A1
overexpression in striatal neuron cell lines from mice resulted in increased ROS and mitochondrial dysfunction46. Knockouts
of F8A1 in human HeLa and HEK293 cells yield altered/reduced autophagy and shorter life spans46. Knockouts of the single
F8A gene in Drosophila similarly show reduced activity, altered/reduced autophagy, and shorter lifespan47.
F8A1 expression is increased under several conditions, including Huntington’s disease48, presence of a SNP variant for
type 1 diabetes risk49, cytotrophoblast-enriched placental tissues in women with severe preeclampsia50, and mesenchymal bone
marrow cells as women age51. Its potential role in the latter conditions has not been investigated.
Altered endosome motility would play an important but complex role in infection and the innate immune response, and
might either promote or hinder the battle between SARS-CoV-2 and its human host22, 52. Coronaviruses including SARS-CoV-2
mainly enter host cells via binding to the ACE2 receptor followed by endocytosis7, 53. Nascent early endosomes are moved along
the microtubule cytoskeleton, fusing with other vesicles; varied molecules can be incorporated into the endosomal membrane or
its interior22, 52. This regulated development enables diverse fates. For example, in the context of SARS-CoV-2, endosomes
might release viral RNA or particles; they might merge with lysosomes and digest their viral cargo; or they might fuse with
autophagosomes (autophagy) and subsequently with lysosomes that digest the cargo22, 52. SARS-CoV-2 might reprogram
cellular metabolism to suppress autophagy and promote viral replication54; conversely, the cell might modify autophagy
machinery to decorate viral invaders with ubiquitin for eventual destruction, activate the immune system by displaying parts of
the virus, or catabolize excess pro-cytokines. Autophagy might induce cytokine signaling, which could promote protective
immune response or engender a destructive storm of cytokines, inflammation and tissue damage22. Because of its function in
early endosome motility, HAP40 has implications as a potential molecular target in therapy of endosomal and autophagy-related
disorders such as COVID-19.
Our analyses using single cell reference data indicate several cell type-specific associations of the signatures of DE genes in
African Americans versus European Americans. One model by which this might occur is that individuals of one population
tend to have different proportions of a given cell type or histological structure. An alternative model is that individuals of
one population might tend to maintain some of their cell types in a state of relatively higher activation. Either explanation
would lead bulk RNA-Seq analyses, such as sample-types from GTEX or TCGA, to demonstrate elevated expression of those
transcripts in that population.
Although at a population level, major differences exist in expression of immunity-related genes and cell-type-specific
associations between African Americans and European Americans, when considered on an individual basis, gene expression
differences are more complex. Individuals within a population may exhibit all, none, or some portion of these differences.
That some genes show bimodal expression distribution in some sample-types African American and/or European American
populations further emphasizes this variation.
Thus, the significance of these patterns and their relationship to differential susceptibility or risk of severity from COVID-19
infection must be considered from nuanced perspectives. Importantly, it may be that only a fraction of the signature and a
fraction of the individuals in a population are at elevated risk of more severe disease. In addition, different mechanisms of risk
may be operative within different individuals within an population. For example, elevated abundance or activity of cells that are
the target of COVID-19 (e.g., ACE2-positive basal keratinocytes) could lead to a greater infection burst during initial phases
with a larger number of virions being released systemically. If, as it appears from the alignment of the DE genes in African
American compared to European Americans to the lung single cell data, this is the case for African American-individuals, then
they might be more readily taken over by infecting SARS-Cov2 virions.
The differential expression of genes implicated in COVID-19 morbidity and mortality between African Americans and
European Americans reported herein emphasizes the importance of integrating gene expression data into the factors considered
in studying this pandemic at a population level. Further, RNA-Seq data has been shown useful in clinical practice for pediatric
cancers55, and this practice could be extended to other diseases. We hypothesize, in concurrence with17, 56, that processes
of disease- and stress-related genes are overrepresented among the DE genes of African American and European American
populations in part because the ancestral selection pressure due to disease and stresses (such as temperature and toxins) was
very strong, with very different complements of pathogens and stresses in the regions where these populations lived. To survive,
humans living in Europe and those living in Western Africa would have had to evolve the ability to resist the diverse prevalent
local pathogens and stresses. Other differences would be due to a difference in socioeconomic environment57.
The utility of expression data is tremendous, but it is reliant on adequate representation of cohorts and on sufficient metadata.
For example, ethnic bias and practical factors (such as subject availability) often result in insufficient numbers of subjects from
many populations being represented in medical studies58, 59; this lack of representation impedes the development of precision
prognosis and therapy based on genetics34, 58. Here, we were limited to comparison of differences between gene expression in
African American and European American populations because even in the large GTEx and TCGA studies, sample sizes for
the other three major population groups (Asian, Native American, and Pacific Islanders) were generally too low for robust
statistical assessment (Supplementary Table S1).
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In addition, even if sample sizes for race are sufficient, information on the ancestry of each individual sampled is needed.
Self-reported metadata on race is often not publicly available for individual samples. However, methods of assigning ancestry
to individuals sampled for RNA-Seq are being developed and applied60, 61
A major dichotomy exists between socio-economic and genomic investigations. Among the vast body of human RNA-Seq
data deposited, not only are metadata on the ancestry of the sampled individuals often unavailable, but socio-economic
metadata (postal code, education, income, occupation) are almost never present. Thus, apart from the pioneering sociogenomics
research of57, 57, 62 and the studies of56, 63, 64, socioeconomic information are rarely considered in ’omics analyses. Indeed,
because of the scant metadata on socioeconomic determinants it is not even possible to determine possible skewness of
representation of socioeconomic groups among the individuals sampled; thus, socioeconomic factors represent high-impact
complex hidden covariates that would be challenging to model. Conversely, sociological studies rarely incorporate ’omics
information. For example, the U.S.-based Robert Wood Johnson Foundation (https://www.rwjf.org/en/library/
interactives/whereyouliveaffectshowlongyoulive.html) cites research that "your zip code can be more
important than your genetic code" for your health; however, the analyses were done without actually evaluating genetic codes.
Because socioeconomic data was absent in this study, we were unable to distinguish genetic effects from socioeconomic
causes. Despite having metadata on ancestry, we could not resolve the component due to genetics, from that to socioeconomic
factors, and were limited to reporting population-based differences in gene expression (rather than ancestry-based differences).
Privacy concerns need to be carefully balanced against the very real health benefits that can be gained from metadata access.
Without routine inclusion and availability of diverse metadata for human ’omics samples, data mining is hampered, and
important information is lost.
In summary, multiple genes implicated in COVID-19 immunity and inflammation are DE across African American and
European American populations. This differential expression is evident despite the fact that race is self-reported in the metadata,
and many Americans are racially admixed21. By highlighting the wide-ranging differences in expression of genes implicated
in the morbidity and mortality of COVID-19 across populations, and by revealing apparent cell-type differences between
populations, we provide a baseline for future study and emphasize the importance of harvesting these types of information for




GTEx provides data representing “non-diseased” samples from diverse tissues. Non-diseased refers to the tissue itself, however,
in some cases the individual sampled was postmortem and the causes of death are varied. TCGA project is the largest project
available on different diseased samples (tumors) of multiple tissue origins. Both projects have metadata on the (self-reported)
races of the individuals who contributed samples. These two projects provide a unique opportunity to evaluate differences in
gene expression across populations in multiple sample-types that vary by tissue and disease status. Tissues and cancers were
selected for downstream analysis based largely on having sufficient numbers of individuals from each ancestry. We refer to
those self-reporting as “Black or African American” as “African Americans” and “White” as “European Americans”.
The data files and the precompiled MOG project, MOG_HumanCancerRNASeqProject, were downloaded from http://
metnetweb.gdcb.iastate.edu/MetNet_MetaOmGraph.htm18. This project uses batch-corrected and processed
data to enable comparison across samples19. MOG_HumanCancerRNASeqProject contains expression values for 18,212 genes,
30 fields of metadata detailing each gene, across 7,142 samples representing 14 different cancer types and associated non-tumor
tissues (TCGA and GTEX samples) integrated with 23 fields of metadata describing each study and sample18.
Statistical and correlation analyses
The MOG tool was used to interactively explore, visualize and perform differential expression and correlation analysis of genes.
The Mann-Whitney (MW) test was used to identify DE genes between two groups; we chose this non-parametric analysis
as it makes no assumptions about the data distribution. We define a gene as DE 2-fold or more between two groups if it meets
each of the following criteria:
1. Estimated fold-change in expression of 2-fold or more (log fold change, |logFC| ě 1), where logFC is calculated as in
limma65.)
2. Mann-–Whitney U test is significant between the two groups (Benjamini-Hochberg (BH) corrected p-value ă 0.05)
Pearson correlation values and Mutual Information values were computed after data was log2 transformed within MOG, in




To check for potential sampling differences between populations that might confound the analysis, we fit linear models using
limma65 in R, to adjust for for biologically relevant, potential confounding factors of race, gender, tissue/tumor type, age and
cancer subtypes. (Supplementary Table S29-S55). Because ratios of cancer sub-types may differ between races (as reported
for breast cancer in premenopausal African American women), we evaluated the RNA-Seq data from African Americans and
European Americans in BRCA samples for potential confounding effects due to different ratios of four breast cancer subtypes:
basal-like (BAS), human epidermal growth factor receptor-2 positive/estrogen receptor negative (Her2), luminal A (LumA),
and luminal B (LumB); all genes DE with an >2-fold change in MW analysis retained statistical significance in limma analysis
of BRCA data, although the fold-change level varied (Supplementary Table S41).
To assess whether a given distribution shows bi- or multi-modality we applied the Hartigans’ dip (Dip) test, using the R
package diptest (https://cran.r-project.org/package=diptest) (Additional File 1).
Gene expression enrichment
Overrepresentation of biological processes and other functional analysis was assessed at https://toppgene.cchmc.org/. Geneset
enrichment analyses (GSEA) were performed using the clusterProfiler library in R66.
Cell-type analysis
African American-vs-European American gene signatures to cell types and compartments were mapped using cell type
specific gene modules derived from a series of single cell gene expression datasets for esophagus29 and lung28 hosted in
ToppCell (http://toppcell.cchmc.org/) using the ToppGene tool (http://toppgene.cchmc.org/). Heat map visualization of genes
differentially-expressed by African Americans versus European Americans in each cell type module in the selected tissues was
done using Morpheus (https://software.broadinstitute.org/morpheus/) using ToppCell’s "super binned" gene expression for each
cell type within each single cell dataset.
Data availability
We subscribe to an open data model (https://www.go-fair.org/fair-principles/). MOG is free and open source software pub-
lished under the MIT License. MOG software, user guide, and the MOG_HumanCancerRNASeqProject project datasets and
metadata described in this article are freely downloadable from http://metnetweb.gdcb.iastate.edu/MetNet_
MetaOmGraph.htm. MOG’s source code is available at https://github.com/urmi-21/MetaOmGraph/. De-
tailed information and code on how to reproduce the results, along with Additional files, are available at https://github.
com/urmi-21/COVID-DEA.
Supplementary data
Supplementary data are available at https://github.com/urmi-21/COVID-DEA. .
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